Authors:
Ian Roberts, Haleema Shakur-Still, Adefemi Afolabi, Adegboyega Akere, Monica Arribas, Emma Austin, Kiran Bal, Nuha Bazeer, Danielle Beaumont, Amy Brenner, Abdelmounem Abdo (Sudan Lead)
Journal:
The Lancet / Health Technology Assessment
Date:
October 1, 2021
Abstract
Major international RCT across 15 countries including Sudan (NCGLD as country lead). Concluded tranexamic acid did not reduce mortality and increased thromboembolic risk.